Aminoglycoside dosing and monitoring for Pseudomonas aeruginosa during acute pulmonary exacerbations in cystic fibrosis.
Sign Up to like & getrecommendations! Published in 2021 at "Pediatric pulmonology"
DOI: 10.1002/ppul.25441
Abstract: Aminoglycosides are commonly used for the treatment of Pseudomonas aeruginosa (PsA) in the setting of acute pulmonary exacerbations (PEx) in pediatric patients with cystic fibrosis (CF). There are controversies and practice differences between institutions related… read more here.
Keywords: cystic fibrosis; pseudomonas aeruginosa; aminoglycoside dosing; dosing monitoring ... See more keywords
Aminoglycoside Dosing and Volume of Distribution in Critically Ill Surgery Patients.
Sign Up to like & getrecommendations! Published in 2020 at "Surgical infections"
DOI: 10.1089/sur.2020.012
Abstract: Background: At a tertiary referral and Level I trauma center, current institutional guidelines suggest initial aminoglycoside doses of gentamicin or tobramycin 4 mg/kg and amikacin 16 mg/kg for patients admitted to surgical intensive care units (SICUs) with… read more here.
Keywords: peak concentrations; aminoglycoside dosing; ill surgery; critically ill ... See more keywords